Washington: The U.S. Food and Drug Administration (USFDA) announced that it will overhaul packaging labels for the emergency contraceptive pill, Plan B, that women can take after having sex to prevent a pregnancy.

The federal agency said it will remove references on the contraception's packaging that claim, without scientific evidence, that the pill prevents a fertilized egg from implanting in the womb.

The new labels are intended to further distinguish emergency contraception, also known as the "morning after pill," from abortion pills, which end a pregnancy after a fertilized egg has implanted in the lining of a woman's uterus.

Click for more articles on USFDA

In a memo released, the USFDA clarified that taking Plan B pills is not the same as an abortion, a fact that has long been understood in the medical community.

"Evidence does not support that the drug affects implantation or maintenance of a pregnancy after implantation, therefore it does not terminate a pregnancy," the USFDA said in its statement.

The agency added that the emergency contraception works similarly to birth control in preventing pregnancy, but contains a higher dose of levonorgestrel. The pill prevents ovulation.

About a quarter of women say they've used emergency contraception pills at some point, according to a survey by the Centers for Disease Control (CDC) released last year.

Click for more articles on Contraceptive pills

Still, concern has swirled that access to emergency contraception such as Plan B might be limited in some states, after the U.S. Supreme Court overturned the constitutional right to an abortion this summer.

Nevada's Republican governor-elect said he'd consider banning the pill during a debate this year. School clinics in Idaho also prohibited the pills under a law banning public funding for "abortion related services" last year.

The USFDA has approved Plan B for use up to 72 hours, or three days, after unprotected sex. Women are able to get emergency contraception over the counter.

Confession in criminal proceedings: Ground for conviction ?

USFDA gives approval for Lymphoma Therapy

PCI directs State Pharmacy Councils to expedite transfer of registration of Pharmacist

300 life-saving drugs needed from Indian Pharma Cos: Saudi Arab

Registration for sale of Medical Devices: Procedure and conditions

NPPA fixes Retail Price of 10 formulations: December 2022

Drug recall: This Blood Pressure tablets recalled

Kerala to cancel licences of Medical Stores selling antibiotics without prescription

Bulk transfer of Blood and Blood Components: Procedure and Conditions

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/12/25/usfda-changes-plan-b-label-of-contraceptive-pills/